Can-Fite Biopharma (CANF) Q3 2026 Earnings

27AugConfirmed
Q2 2025
Q3 2025
Q1 2026
Next
-2.99
-1.99
-0.99
0

Details

Expected EPS
-0.165
Actual EPS
N/A
Surprise EPS
0.17
Surprise Percent
+100%

Description

Can-Fite Biopharma (CANF) will report earnings of for Q3 2026 on August 27, 2026.

0 Comments

Share your thoughts